0001144204-16-127061.txt : 20161005 0001144204-16-127061.hdr.sgml : 20161005 20161005170242 ACCESSION NUMBER: 0001144204-16-127061 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20160929 ITEM INFORMATION: Changes in Registrant's Certifying Accountant ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20161005 DATE AS OF CHANGE: 20161005 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MUSTANG BIO, INC. CENTRAL INDEX KEY: 0001680048 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 473828760 STATE OF INCORPORATION: DE FISCAL YEAR END: 0312 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-55668 FILM NUMBER: 161923137 BUSINESS ADDRESS: STREET 1: 2 GANSEVOORT STREET STREET 2: 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 BUSINESS PHONE: 7816524507 MAIL ADDRESS: STREET 1: 2 GANSEVOORT STREET STREET 2: 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 8-K 1 v450114_8k.htm FORM 8-K

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

  FORM 8-K  

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): September 29, 2016

 

 

MUSTANG BIO, INC.

  
 

(Exact Name of Registrant as Specified in Charter)

 

  
Delaware 000-55668 47-3828760

(State or Other Jurisdiction

of Incorporation)

 

 

 (Commission File Number)

(IRS Employer

Identification No.)

             2 Gansevoort Street, 9th Floor, New York, New York                     10014
                     (Address of Principal Executive Offices)                                      (Zip Code)
         

 

Registrant’s Telephone Number, Including Area Code: (781) 652-4500

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

 

Item 4.01.Changes in Registrant’s Certifying Accountant.

 

(a)       Previous independent registered public accounting firm.

 

On September 29, 2016, Mustang Bio, Inc. (the “Company”) dismissed Mayer Hoffman McCann P.C. (“Mayer Hoffman”) as the Company’s independent registered public accounting firm. The Company’s Board of Directors participated in and approved this decision.

 

The reports of Mayer Hoffman on the consolidated financial statements of the Company for the fiscal period from March 13, 2015 (inception) to December 31, 2015, did not contain an adverse opinion or a disclaimer of opinion, nor were such reports qualified or modified as to uncertainty, audit scope, or accounting principles, except that, the audit report included an explanatory paragraph with respect to the uncertainty as to the Company’s ability to continue as a going concern.

 

During the Company’s fiscal period from March 13, 2015 (inception) to December 31, 2015, and during the subsequent interim periods preceding the date of Mayer Hoffman’s dismissal, the Company did not have any disagreements with Mayer Hoffman on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which disagreements, if not resolved to the satisfaction of Mayer Hoffman, would have caused it to make reference to the subject matter of the disagreements in connection with its reports on the consolidated financial statements for such time periods.

 

During the Company’s fiscal period from March 13, 2015 (inception) to December 31, 2015, and during the subsequent interim periods preceding the date of Mayer Hoffman’s dismissal, no “reportable events” as defined in Item 304(a)(1)(v) of Regulation S-K have occurred.

 

Mayer Hoffman has indicated to the Company that it concurs with the foregoing statements contained in the second, third and fourth paragraphs above as they relate to Mayer Hoffman and has furnished a letter to the Securities and Exchange Commission to this effect. A copy of the letter from Mayer Hoffman is attached to this Form 8-K as Exhibit 16.1.

 

The Company will retain BDO USA, LLP (“BDO”) as its new independent registered public accounting firm and will file an additional Current Report on Form 8-K when it formally engages BDO.

 

Item 9.01.Financial Statements and Exhibits.

 

(d)Exhibits.

 

Exhibit No.Description

 

16.1Letter from Mayer Hoffman McCann P.C. to the Securities and Exchange Commission dated October 5, 2016.

 

 

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  Mustang Bio, Inc.
   
Date:  October 5, 2016 /s/ Michael S. Weiss                                       
  Name: Michael S. Weiss
  Title:   President and Chief Executive Officer

 

 

 

 

 

INDEX TO EXHIBITS

 

 

Exhibit  
Number Description
   
16.1 Letter from Mayer Hoffman McCann P.C. to the Securities and Exchange Commission dated October 5, 2016.

 

 

 

 EX-16.1 2 v450114_ex16-1.htm EXHIBIT 16.1

 

Exhibit 16.1

 

Securities and Exchange Commission

100 First Street, N.E.

Washington, D.C. 20549

 

Ladies and Gentlemen:

 

We were previously independent accountants for Mustang Bio, Inc. (the “Company”). On September 29, 2016, our appointment as the Company’s independent accountants was terminated. We have read the Company’s statements included under item 4 of its Current Report on Form 8-K dated on or about October 5, 2016, and we agree with the statements set forth therein insofar as such comments relate to us.

 

 
Very truly yours,
 
/s/ Mayer Hoffman McCann, P.C.
 
Mayer Hoffman McCann, P.C.
Orange County, California